C3 production of cultured human epidermal keratinocytes is enhanced by IFNγ and TNFα through different pathways

Journal of Investigative Dermatology

Volumn 108, Issue 1, 1997, Pages 62-67

  Terui, Tadashi ^a   Ishii, Kuniaki ^a   Ozawa, Maki ^a   Tabata, Nobuko ^a   Kato, Taizo ^a   Tagami, Hachiro ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C3; Human; IFN ; Keratinocyte; TNF

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; COMPLEMENT COMPONENT C3; GAMMA INTERFERON; GENISTEIN; HERBIMYCIN A; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA; TYRPHOSTIN; VANADIC ACID;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL;

EID: 0031014366     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12285633     Document Type: Article

References (39)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595, 1987
2. Alper CA, Johnson AM, Birtch AG, Moor FD: Human C3: evidence for the liver as the primary site of synthesis. Science 163:286-288, 1969
3. Andoh A, Fujiyama Y, Bamba T, Hosoda S: Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 151:4239-4247, 1993
4. Basset-Seguin N, Caughman SW, Yancey KB: A-431 cells and human keratinocytes synthesize and secrete the third component of complement. J Invest Dermatol 95:621-625, 1990
5. Bigler CF, Norris DA, Weston WL, Arend WP: Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 98:38-44, 1992
6. Botto M, Lissandrini D, Sorio C, Walport MJ: Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J Immunol 149:1348-1355, 1992
7. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M: Prolonged activation of jun and collagenase genes by tumour necrosis factor-α. Nature 337:661-663, 1989
8. Brooimans RA, Stegmann AP, Van Dorp WT, Van Der Ark AA, Van Der Wounde FJ, Van Es LA, Daha MR: Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 88:379-384, 1991
9. Brooimans RA, Van Der Ark AA, Buurman WA, Van Es LA, Daha MR: Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFNγ and IL-1. J Immunol 144:3835-3840, 1990
10. Dvir A, Milner Y, Chomsky O, Gilon C, Gazit A, Levitzki A: The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers. J Cell Biol 113:857-865, 1991
11. Filvaroff E, Calautti E, Reiss M, Dotto GP: Functional evidence for an extracellular calcium receptor mechanism triggering tyrosine kinase activation associated with mouse keratinocyte differentiation. J Biol Chem 269:21735-21740, 1994
12. Gazit A, Yaish P, Gilon C, Levitzki A: Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem 32:2344-2352, 1989
13. George MD, Vollberg TM, Floyd EER, Stein JP, Jetten AM: Regulation of transglutaminase type II by transforming growth factor-β1 in normal and transformed human epidermal keratinocytes. J Biol Chem 265:11098-11104, 1990
14. Hamilton AO, Jones L, Morrison L, Whaley K: Modulation of monocyte complement synthesis by interferons. Biochem J 242:809-815, 1987
15. Hayakawa M, Ishida N, Takeuchi K, Shibamoto S, Hori S, Oku N, Ito F, Tsujimoto M: Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 268:11290-11295, 1993
16. Hunter T, Cooper JA: Protein tyrosine kinases. Annu Rev Biochem 54:897-930, 1985
17. Katz Y, Revel M, Strunk RC: Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts. Eur J Immunol 19:983-988, 1989
18. 2/IL-6 genes in human fibroblasts. J Immunol 142:3862-3867, 1989
19. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Lugar TA: Human keratinocytes are a source for tumor necrosis factor α: Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172: 1609-1614, 1990
20. Kulics J, Colten HR, Perlmutter DH: Counterregulatory effects of interferon-γ and endotoxin on expression of the human C4 genes. J Clin Invest 85:943-949, 1990
21. Kupper TS: The activated keratinocytes: A model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 94:146S-150S, 1990
22. Lappin DF, Guc D, Hill A, McShane T, Whaley K: Effect of interferon-γ on complement gene expression in different cell types. Biochem J 281:437-442, 1992
23. Lenardo MJ, Baltimore D: NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227-229, 1989
24. Matsui MS, Chew SL, DeLeo VA: Protein kinase C in normal human epidermal keratinocytes during proliferation and calcium-induced differentiation. J Invest Dermatol 99:565-571, 1992
25. Perlmutter DH, Dinarello CA, Punsal PI, Colten HR: Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 78:1349-1354, 1986a
26. Perlmutter DH, Goldberger G, Dinarello CA, Mizel SB, Colten HR: Regulation of class III major histocompatibility complex gene products by interleukin-1. Science 232:850-852, 1986b
27. Ramadori G, Van Damme J, Rieder H, Meyer Zum Buschenfelde KH: Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse: Comparison with interleukin 1β and tumor necrosis factor-α. Eur J Immunol 18:1259-1264, 1988
28. Reiners Jr JJ, Slaga TJ: Effects of tumor promoters on the rate and commitment to terminal differentiation of subpopulations of murine keratinocytes. Cell 32:247-255, 1983
29. Sackstein R, Colten HR: Molecular regulation of MHC class III (C4 and factor B) gene expression in mouse peritoneal macrophages. J Immunol 133:1618-1626, 1984
30. Saunders NA, Jetten AM: Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon γ. Antagonism by retinoic acid and transforming growth factor β1. J Biol Chem 269:2016-2022, 1994
31. Strunk RC, Eidlen DM, Mason RJ: Pulmonary elveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 81:1419-1426, 1988
32. Terui T, Kato T, Tagami H: Stratum corneum activation of complement through the antibody-independent alternative pathway. J Invest Dermatol 92:593-597, 1989
33. Terui T, Zhen Y-X, Kato T, Tagami H: Mechanism of human polymorphonuclear leukocyte adhesion to serum-treated corneocytes. J Invest Dermatol 104:297-301, 1995
34. Uehara Y, Fukazawa H, Murakami Y, Mizuno S: Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by surfhydryl compounds. Biochem Biophys Res Commun 163:803-809, 1989
35. Westwick JK, Weitzel C, Minden A, Karin M, Brenner DA: Tumor necrosis factor α stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J Biol Chem 269:26396-26401, 1994
36. Yancey KB, Overholser O, Domloge-Hultsch N, Li L-J, Caughman SW, Bisalbutra P: Human keratinocytes and A-431 cells synthesize and secrete factor B, the major zymosan protease of the alternative complement pathway. J Invest Dermatol 98:379-383, 1992
37. Yang Z, Costanzo M, Golde DW, Kolesnick RN: Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kB translocation in intact HL-60 cells. J Biol Chem 268:20520-20523, 1993
38. Yuspa SH, Ben T, Hennings H, Lichit U: Phorbol ester tumor promoters induce epidermal transglutaminase activity. Biochem Biophys Res Commun 97:700-708, 1982
39. Zhao Y, Uyttendaele H, Krueger JG, Sudol M, Hanafusa H: Inactivation of c-Yes tyrosine kinase by elevation of intracellular calcium levels. Mol Cell Biol 13:7607-7514, 1993